Cancer drug delays ‘costing lives’, says lobby group

02 February 2020 - 00:00 By SIPOKAZI FOKAZI

After two bouts of blood cancer and two bone-marrow transplants in seven years, Retha Wessels hoped her problems were over.

But red tape and health-care economics have combined to land her with a R25,000 monthly bill for an anticancer drug, Revlimid...

This article is reserved for Sunday Times subscribers.

A subscription gives you full digital access to all Sunday Times content.

Already subscribed? Simply sign in below.

Registered on the BusinessLIVE, Business Day, Financial Mail or Rand Daily Mail websites? Sign in with the same details.

Questions or problems? Email or call 0860 52 52 00.